FSH is no longer the standard by which to gauge a woman’s ovarian reserve or predict successful outcome with fertility treatment. This, according to Dr. David Seifer, Co-director of Genesis Fertility and Reproductive Medicine in Brooklyn, NY. In an article published in Fertility and Sterility, he and Dr. James Toner makes the case that AMH, Antimullerian Hormone, is a more informative and better test than FSH, Follicle Stimulating Hormone.
By examining the chromosomes in an embyro using preimplantation genetic screening and only implanting healthy, normal embryos, doctors can reduce the miscarriage rate, explains Dr. Jamie Grifo, Program Director of the NYU Fertility Center and Director of the Division of Reproductive Endocrinology, NYU School of Medicine.
“Most of our lives, our eggs are in a state of suspended animation as immature cells but in the three to four months before ovulation, an egg must undergo a major transformation," writes author Rebecca Fett in her book It Starts With The Egg. "It grows dramatically in size and starts producing much more energy. The egg must then execute a precise process of separating and ejecting copies of chromosomes.”
Think Diminished Ovarian Reserve means your eggs are bad? Dr. Owen Davis of the Center for Reproductive Medicine at Cornell says there is a big difference between quality and quantity when it comes to ovarian reserve and chances for IVF success.